Search clinical trials for: Administration of glucose and controlled induction of hypoglycaemia.

Total 17654 results

The People's Hospital of Gaozhou

Recruiting

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

China
Instituto Nacional de Ciencias Medicas y Nutricion...
Olynka Vega Vega; Noemi del Toro Cisneros; Miguel Ángel Martínez Rojas

Recruiting

Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study (DAKI-CKD)

Biomarkers | CKD | AKI - Acute Kidney Injury | Transition to CKD

Mexico
AstraZeneca

Terminated

The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function. (DAPASALT)

Diabetes Mellitus, Type 2 | Kidney Function Tests

Netherlands, Sweden
AstraZeneca

Completed

Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles. (DAPAMAAST)

Diabetes Mellitus, Type 2 | Skeletal Muscle Insulin Sensitivity

Netherlands
AstraZeneca
Bristol-Myers Squibb

Completed

A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose

Healthy Volunteers

Germany
Novo Nordisk A/S

Recruiting

A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

Diabetes Mellitus, Type 2

Austria
Beijing Friendship Hospital

Enrolling by invitation

Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV

CAEBV | PTLD | HLH

China
Dragonboat Biopharmaceutical Company Limited
Shanghai East Hospital

Unknown

Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors

Advanced Tumors

China
University of Edinburgh
NHS Lothian; DexCom, Inc.; Tandem Diabetes Care, Inc.; The Leona M. and Harry B...

Active, not recruiting

Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes | Type 1 Diabetes Mellitus With Hypoglycemia | Hypoglycemia Unawareness | Glucagon Deficiency | Insulin Hypoglycemia

United Kingdom
Mohamed Nabil Elkholy

Recruiting

Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients

STEMI

Egypt
Chinese University of Hong Kong

Recruiting

Dapa Acute Heart Failure Study

Heart Failure

Hong Kong
China National Center for Cardiovascular Diseases

Recruiting

Dapagliflozin Therapy In Cardiac Surgery

Diabetes Mellitus, Type 2 | Cardiac Surgery

China
Children's Hospital of Fudan University

Completed

Efficacy and Safety of Dapagliflozin in Children With Proteinuria

Proteinuria

China
The University of Hong Kong

Active, not recruiting

The Effects of SGLTi on Diabetic Cardiomyopathy (SGLTi)

Type2 Diabetes | Heart Failure With Reduced Ejection Fraction

Hong Kong
University of Ioannina

Completed

Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy

Diabetes

Greece
AstraZeneca
Bristol-Myers Squibb

Completed

Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 10773 Administered Twice Daily Compared BI 10773 Given Once Daily After Multiple Oral Doses in Healthy Male and Female Volunteers

Healthy

Germany
Seoul National University Hospital
AstraZeneca

Completed

Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell

Diabetes Mellitus, Type 2

Korea, Republic of
Johnson & Johnson Pharmaceutical Research & Development...

Completed

The Effect of Food on the Administration of Canagliflozin in Healthy Adult Volunteers

Healthy
Cline Research Center
Abbott Diabetes Care

Completed

Time in Range (TIR) and Time Below Range (TBR) in Insulin-Treated Elderly Patients With Type 2 Diabetes

Continuous Glucose Monitoring

Brazil
HealthPartners Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes

Diabetes | Insulin

United States
Yale University

Completed

Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes

Cystic Fibrosis | Cystic Fibrosis Related Diabetes

United States
Asan Medical Center
HanAll BioPharma Co., Ltd.

Completed

Clinical Trial to Compare the Pharmacokinetics and Pharmacodynamics After Oral Administration of Glucophage and HL-018

Healthy

Korea, Republic of
Korea United Pharm. Inc.

Completed

Drug-drug Interaction Study Between UIC201601 and UIC201602

Healthy
Centre Hospitalier Universitaire Dijon

Completed

Effect of Oral Water on the Quality of Volume Expansion in Resuscitation Patients (WATER)

Intubated-ventilated Patients in the Intensive Care Unit

France
University of Minnesota

Recruiting

FAM (Follower, Action Plan, and Remote Monitoring) Intervention to Reduce Severe Hyperglycemia in Adults With Type 1 Diabetes Mellitus at Risk for Diabetic Ketoacidosis

Type 1 Diabetes

United States
Queen's University, Belfast

Withdrawn

Doppler Ultrasound Investigation of Microcirculations

Type 1 Diabetes Mellitus

United Kingdom
Yale University
American Heart Association

Recruiting

Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study (SGLT2i in CRS)

Cardiorenal Syndrome

United States
University of Campinas, Brazil

Recruiting

DApagliflozin Cardiovascular Effects on Patients at End-stage REnal Disease (Dare-Esrd)

End-stage Kidney Disease

Brazil
Sun Jia

Completed

Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet.

Overweight | Carbohydrate | Sodium-glucose Transporter 2 Inhibitors

China
Fundacion para la Formacion e Investigacion Sanitarias...
Spanish Society of Cardiology

Completed

Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure . (MODA)

Heart Failure

Spain
Medical University Innsbruck
Medical University of Graz; University of Bern

Completed

Dapagliflozin in Type 1 Diabetes (DapaT1DM)

Glycemic Control | Fasting Glucose | Glucose Excursion

Austria
Boehringer Ingelheim

Completed

A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017

Type 2 Diabetes Mellitus

Sweden
Huashan Hospital

Unknown

A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy

Cardiomyopathies | Acromegaly

China
AstraZeneca
Bristol-Myers Squibb

Completed

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

Type 2 Diabetes Mellitus

United States, Mexico
AstraZeneca
Bristol-Myers Squibb

Completed

Renal Impairment in Type 2 Diabetic Subjects

Diabetes Mellitus, Type 2

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

Type2 Diabetes | High Blood Sugar

Japan
AstraZeneca
Bristol-Myers Squibb

Completed

Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

Japan
Mabwell (Shanghai) Bioscience Co., Ltd.

Unknown

Safety, Tolerability, and Pharmacokinetics of MW11 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Tanta University
Mansoura University

Recruiting

Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression

Renal Insufficiency, Chronic

Egypt
Johns Hopkins University

Terminated

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

United States
Tampere University Hospital
Turku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaborators

Completed

Metformin Use to Improve Pregnancy Outcome in Women With Type 1 Diabetes.

Type1diabetes | Insulin Resistance | Diabetic Pregnancy

Finland
University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research

Recruiting

Neuronostatin - a Glucagonotropic Agent in Humans? (NSTCLAMP)

Hypoglycemia | Type1diabetes | Type 1 Diabetes

Denmark
University of Guadalajara

Active, not recruiting

Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Mexico
National Institute of Diabetes and Digestive and...

Completed

Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

HIV Infections | Insulin Resistance | Lipodystrophy

United States
Rabin Medical Center

Completed

Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm

Diabetes, Type I

Israel
University of Sao Paulo

Recruiting

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

Myocardial Infarction | Diabetes | Acute Coronary Syndrome | Ventricular Dysfunction

Brazil
Hamad Medical Corporation

Recruiting

Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery

Atrial Fibrillation

Qatar
University of Minnesota

Recruiting

SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot

Acute Kidney Injury

United States
Fayoum University
Cairo University; NewGiza University

Not yet recruiting

Prevent Diabetic Kidney Disease Among Egyptians

Diabetes Mellitus Without Complication

Search clinical trials for: Administration of glucose and controlled induction of hypoglycaemia.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations